Ikarian Capital, LLC Amgen Inc Call Options Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $45 Million - $49.1 Million	145,400 Added 24233.33%	146,000 $47 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $15.6 Million - $19 Million	-59,400 Reduced 99.0%	600 $187,000
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $6.72 Million - $8.11 Million	25,000 Added 71.43%	60,000 $17.1 Million
Q4 2023 Feb 14, 2024	BUY	$255.7 - $288.46 $8.95 Million - $10.1 Million	35,000 New	35,000 $10.1 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $21.9 Million - $24.3 Million	100,000 New	100,000 $24.2 Million

3,121

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.